Basis of Presentation - Narrative (Details) - USD ($)				3 Months Ended						9 Months Ended
	Jul. 27, 2021	Jun. 30, 2021	Jun. 23, 2021	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Sep. 30, 2021	Sep. 30, 2020	Jun. 02, 2021	Dec. 31, 2020
Organization, Consolidation And Presentation Of Financial Statements [Line Items]
Working Capital Deficiency				$ 2,300,000						$ 2,300,000
Deferred revenue				3,709,005						3,709,005			$ 4,603,270
Total Stockholders' Deficit				(11,499,680)						(11,499,680)			(14,608,186)
Net income (loss)				374,432	$ (349,684)	$ 425,248	$ 1,546,209	$ 406,558	$ (719,840)	449,996	$ 1,232,927
Net cash used in operating activities										(707,889)	(303,299)
Cash and cash equivalents				3,474,784						3,474,784			1,920,656
Cash Period Change										1,600,000
Stock Issued During Period, Shares, New Issues	285,000
Stock Issued During Period, Value, New Issues	$ 900,000		$ 2,700,000	948,566	2,737,770
Shares Issued, Price Per Share	$ 4.10		$ 4.10
Proceeds from public offering, net of underwriting discounts paid										4,181,908	0
Repayments of Short-term Debt		$ 1,300,000			$ 1,334,058					1,334,058	$ 1,000,000
Series A redeemable convertible preferred stock, redemption value				$ 14,195,475						$ 14,195,475			$ 13,346,577
Common Stock
Organization, Consolidation And Presentation Of Financial Statements [Line Items]
Stock Issued During Period, Shares, New Issues			811,750	285,000	811,750
Stock Issued During Period, Value, New Issues				$ 285	$ 812
Common Stock | Over-Allotment
Organization, Consolidation And Presentation Of Financial Statements [Line Items]
Stock Issued During Period, Shares, New Issues			86,750
Amended and Restated Loan Agreement
Organization, Consolidation And Presentation Of Financial Statements [Line Items]
Notes payable												$ 3,500,000
Amended and Restated Loan Agreement | HCP-FVA, LLC
Organization, Consolidation And Presentation Of Financial Statements [Line Items]
Notes payable												$ 2,200,000